Tonix Pharmaceuticals (TNXP) Misses Q4 EPS by 5c

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q4 EPS of ($0.71), $0.05 worse than the analyst estimate of ($0.66).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• UBS Upgrades Apollo Tyres (APTY:IN) to Buy
• Tonix Pharma CEO named interim chief medical officer